期刊文献+

绿脓杆菌外毒素A与Ⅱ型单纯疱疹病毒糖蛋白嵌合表达质粒的构建及其免疫原性的研究 被引量:2

Study of the chimeras of Pseudomonas aeruginosa exotoxin A and HSV-2-gD and its immunogenicity
下载PDF
导出
摘要 构建外毒素结构域Ia基(EPA103)与Ⅱ型单纯疱疹病毒糖蛋白(HSV-2-gD)嵌合蛋白表达载体(pET-EgD),得到嵌合表达蛋白.利用外毒素结构域Ia基因表达蛋白的佐剂效应,以pET-EgD表达嵌合蛋白免疫Balb/c小鼠.结果显示:嵌合表达蛋白(pET-EgD)免疫小鼠,可在小鼠体内诱导产生抗HSV-2特异性抗体.嵌合表达蛋白(pET-EgD)具有较强的免疫原性,为开发研究Ⅱ型单纯疱疹核酸疫苗奠定了基础. The chimeras were constructed with pET-EPA103 and HSV-2-gD by using the molecular cloning technique and the chimeras protein pET-EgD was used to immune Balb/c mice. The results showed that chimeras protein could stimulate mice to produce anti-HSV-2 specific antibody. All of these showed that pET-EgD has the function of immunogenicity and this would provide the basis for research into the molecular adjuvant of nucleic acid vaccine.
出处 《兰州大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第5期48-51,共4页 Journal of Lanzhou University(Natural Sciences)
基金 甘肃省自然科学基金资助项目(ZS051-A25-094).
关键词 绿脓杆菌外毒素A 结构域Ⅰa 嵌合表达 Pseudomonas aeruginosa exotoxin A Domain Ia chimeras
  • 相关文献

参考文献15

  • 1Liu P V. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis Ⅲ identity of the lethal toxin produced in vitro and in vivo[J].Infection Disease, 1966, 116: 481-489.
  • 2Allured V S, Collier R J, Carroll S F, et al. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom[J]. Proc Natl Acad Sci USA, 1986,83: 1320-1324.
  • 3Hwang J, Fitzgerald D J, Adhya S, et al. Functional domains of Pseudomonas exotoxin identified by deletionanalysis of gene expressed in E. coli[J].Cell, 1987, 48: 129-136.
  • 4Manhart M D, Morris R E, Bonventre P F, et al.Evidence for Pseudomonas aeruginosa troxin A.receptor on plasma membrane of toxin sensitive LM fibroblast[J]. Infection and Immunity, 1984,45: 596-603.
  • 5Kounnas M Z, Morris R E, Thompson M R, et al.The alpha 2-macroglobulin, reception/low densit liproprotein, recepto-related protein binds and interlizes Pseudomonas aeruginosa toxin A[J]. J Biol Chem, 1992, 267: 12420-12423.
  • 6Fitzgerald D J, Frying A C, Zdanovsky C B, et al.Pseudomonas aeruginosa exotoxin A related selection yields cells with altered expression of low density liproprotein receptor-related protein[J]. J Cell Biol, 1984, 129: 1533-1541.
  • 7Fitzgerald D, Morris R E, Saelinger C B. Receptormediated interlization of Pseudomonas aeruginosa exotoxin by mouse fibroblast[J]. Cell, 1980, 21: 867-873.
  • 8Wileman T, Harding C, Stani P. Receptor-mediated endocytosis[J]. J Bioche-mecal, 1985, 232: 1-14.
  • 9David N , Taylor A, Jerald Sadoff, et al. Synthesis characterization and clinical enevaluation of conjugate vaccine composed of the O-specific polysaccharides of Shigella dysenteriae tobacterial toxoid[J].Infection and Immunity, 1993, 61: 3678-3687.
  • 10Dani Cohen, Shai Ashkenazi, Manfred Green, et al.Safty and immuneogenicity of investingational.Shigella conjugate vaccine in Irsaely volunteers[J].Infection Immun, 1996, 64: 4074-4077.

二级参考文献6

  • 1Randal L, Mrsny J,Ann L ,et al. Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses[J].Vaccine1999,(17):1425-1433.
  • 2Herzenberg LA, Tokuhisa T. Epitope-specific regulation I Carrer-specific suppression[J]. Nature 1980,285:664-667.
  • 3Liu PV.The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. III.Identity of the lethal toxin produced in vitro and in vivo[J]. J Infection Disease 1966(116):481-489.
  • 4Guidi RC,Collier RJ. Exotoxin A of Pseudomonas aeruginosa evidence that domain I functions in receptor binding[J].Mol Microbiol 1987,(1):57-72.
  • 5Schutze MP, Leecrec C, Jolivet M, et al.Career-induced epitopic suppression.A major issue for future sythetic vaccine[J]. J Immunology 1985,135:2319-1322.
  • 6David J, FitxGerald,Charlotte M,et al. Characterixation of V3 loop-Pseud omonas exotoxin chimeras[J]. Biol Chem 1998,273(16):9951-9958.

同被引文献33

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部